Letrozole versus tamoxifen in the treatment of advanced breast cancer and as neoadjuvant therapy
Author:
- 1 September 2003
- journal article
- clinical trial
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 86 (3-5) , 289-293
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Randomized comparison of tamoxifen and two separate doses of toremifene in postmenopausal patients with metastatic breast cancer.Journal of Clinical Oncology, 1995
- Hormonal treatment for metastatic breast cancer. An eastern cooperative oncology group phase III trial comparing aminoglutethimide to tamoxifenCancer, 1994
- Randomized comparison of the effects of tamoxifen, megestrol acetate, or tamoxifen plus megestrol acetate on treatment response and survival in patients with metastatic breast cancerAnnals of Oncology, 1993
- Primary endocrine therapy for advanced breast cancer: To start with tamoxifen or with medroxyprogesterone acetate?Annals of Oncology, 1993
- Megestrol acetate versus tamoxifen in advanced breast cancer: 5-year analysis--a phase III trial of the Piedmont Oncology Association.Journal of Clinical Oncology, 1988
- Hormonal treatment of advanced breast cancer. A randomized trial of tamoxifenVersus nandrolone decanoateCancer, 1987
- A randomized trial of aminoglutethimide versus tamoxifen in metastatic breast cancerCancer, 1982
- Randomized clinical trial of megestrol acetate versus tamoxifen in paramenopausal or castrated women with advanced breast cancerAmerican Journal of Clinical Oncology, 1982
- Tamoxifen versus aminoglutethimide in advanced breast carcinoma: a randomized cross-over trial.BMJ, 1981
- Randomized Clinical Trial of Diethylstilbestrol versus Tamoxifen in Postmenopausal Women with Advanced Breast CancerNew England Journal of Medicine, 1981